FDA approves new therapy for double-positive metastatic breast cancer

[News]

The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic breast cancer based on results of the phase 3 PATINA study led by Otto Metzger, MD, Associate Medical Director of International Strategic Initiatives at Dana-Farber Cancer Institute.

More... (https://www.news-medical.net/news/20260706/FDA-approves-new-therapy-for-double-positive-metastatic-breast-cancer.aspx)